WASHINGTON (dpa-AFX) - After gapping open sharply lower, shares of Array BioPharma (ARRY) have shown a significant rebound over the course of the trading day on Thursday. Array is currently up by 2.6 percent.
The initial sell-off by Array came after the biopharmaceutical company announced it has commenced an underwritten public offering of $175 million worth of shares of its common stock.
Copyright RTT News/dpa-AFX